515 related articles for article (PubMed ID: 16180912)
1. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
Roy K; Leonard JT
J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
[TBL] [Abstract][Full Text] [Related]
2. QSAR by LFER model of cytotoxicity data of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives using principal component factor analysis and genetic function approximation.
Roy K; Leonard JT
Bioorg Med Chem; 2005 Apr; 13(8):2967-73. PubMed ID: 15781406
[TBL] [Abstract][Full Text] [Related]
3. Comparative QSAR modeling of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas.
Thomas Leonard J; Roy K
Bioorg Med Chem Lett; 2006 Sep; 16(17):4467-74. PubMed ID: 16806923
[TBL] [Abstract][Full Text] [Related]
4. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Leonard JT; Roy K
Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
[TBL] [Abstract][Full Text] [Related]
6. Comparative QSAR modeling of COX-2 inhibitor 1,2-diarylimidazoles using E-state and physicochemical parameters.
Chakraborty S; Sengupta C; Roy K
Indian J Biochem Biophys; 2007 Jun; 44(3):169-75. PubMed ID: 17650586
[TBL] [Abstract][Full Text] [Related]
7. QSAR of antilipid peroxidative activity of substituted benzodioxoles using chemometric tools.
Mitra I; Roy K; Saha A
J Comput Chem; 2009 Dec; 30(16):2712-22. PubMed ID: 19399769
[TBL] [Abstract][Full Text] [Related]
8. QSAR of adenosine receptor antagonists. Part 3: Exploring physicochemical requirements for selective binding of 1,2,4-triazolo[5,1-i]purine derivatives with human adenosine A3 receptor subtype.
Roy K; Leonard JT; Sengupta C
Bioorg Med Chem Lett; 2004 Jul; 14(14):3705-9. PubMed ID: 15203147
[TBL] [Abstract][Full Text] [Related]
9. Exploring QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists using FA and GFA techniques.
Bhattacharya P; Leonard JT; Roy K
Bioorg Med Chem; 2005 Feb; 13(4):1159-65. PubMed ID: 15670924
[TBL] [Abstract][Full Text] [Related]
10. QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques.
Leonard JT; Roy K
Bioorg Med Chem; 2006 Feb; 14(4):1039-46. PubMed ID: 16213730
[TBL] [Abstract][Full Text] [Related]
11. Exploration of rate-limiting conformational state for 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl][1,1'-biphenyl]-2-ols and N(omega)-oxides (tebuquine analogues) for antimalarial activity using molecular shape analysis and molecular field analysis studies.
Sharma P; Chhabra S; Rai N; Ghoshal N
J Chem Inf Model; 2007; 47(3):1087-96. PubMed ID: 17425301
[TBL] [Abstract][Full Text] [Related]
12. CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives.
Imamura S; Nishikawa Y; Ichikawa T; Hattori T; Matsushita Y; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
Bioorg Med Chem; 2005 Jan; 13(2):397-416. PubMed ID: 15598561
[TBL] [Abstract][Full Text] [Related]
13. QSAR of adenosine A3 receptor antagonist 1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives using chemometric tools.
Bhattacharya P; Roy K
Bioorg Med Chem Lett; 2005 Aug; 15(16):3737-43. PubMed ID: 15993066
[TBL] [Abstract][Full Text] [Related]
14. Exploring selectivity requirements for peripheral versus central benzodiazepine receptor binding affinity: QSAR modeling of 2-phenylimidazo[1,2-a]pyridine acetamides using topological and physicochemical descriptors.
Dalai MK; Leonard JT; Roy K
Indian J Biochem Biophys; 2006 Apr; 43(2):105-18. PubMed ID: 16955759
[TBL] [Abstract][Full Text] [Related]
15. QSAR of matrix metalloproteinase inhibitor N-[(substituted phenyl)sulfonyl]-N-4-nitrobenzylglycine hydroxamates using LFER model.
Roy K; Pal DK; De AU; Sengupta C
Drug Des Discov; 2001; 17(4):315-23. PubMed ID: 11765134
[TBL] [Abstract][Full Text] [Related]
16. QSAR of adenosine receptor antagonists: Exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A(3) receptor subtype.
Pran Kishore D; Balakumar C; Raghuram Rao A; Roy PP; Roy K
Bioorg Med Chem Lett; 2011 Jan; 21(2):818-23. PubMed ID: 21163647
[TBL] [Abstract][Full Text] [Related]
17. Exploring QSAR of peripheral benzodiazepine receptor binding affinity of N,N-dialkyl-2-phenylindol-3-yl-glyoxylamides using physico-chemical descriptors.
Roy K; Dalai MK
Indian J Biochem Biophys; 2007 Apr; 44(2):114-21. PubMed ID: 17536340
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
19. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.
Ponce YM; Diaz HG; Zaldivar VR; Torrens F; Castro EA
Bioorg Med Chem; 2004 Oct; 12(20):5331-42. PubMed ID: 15388160
[TBL] [Abstract][Full Text] [Related]
20. Generation of predictive pharmacophore models for CCR5 antagonists: study with piperidine- and piperazine-based compounds as a new class of HIV-1 entry inhibitors.
Debnath AK
J Med Chem; 2003 Oct; 46(21):4501-15. PubMed ID: 14521412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]